Mycobacterium tuberculosis infection DNA vaccine(Inovio/Wistar Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMycobacterium tuberculosis infection DNA vaccine(Inovio/Wistar Institute)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A